July 03, 2017
Article
Oropharyngeal cancer rates have been on the rise in men in the United States in recent years. The low HPV vaccine uptake rate, particularly among young men, is a major cause of the problem.
Revolutionizing CAR T-Cell Therapy to Improve Patient Access
Understanding Financial Toxicity and Navigating the System During Cancer
What Is Immunotherapy-Induced Diabetes?
Breaking Down Every FDA Approval Across Oncology During July 2025